A successful benign prostatic hyperplasia managed by rezum prostate ablation

Logesh S*

Physician Assistant, Urology Department, Kauvery Hospital, Hosur, Tamil Nadu

*Correspondence

Abstract

Benign prostatic hyperplasia is a common urological condition affecting elderly men. It is characterized by non-malignant enlargement of prostate gland, with proliferation of prostatic glandular and stromal tissues, resulting in enlargement of the prostate gland and compression on the prostatic urethra. This may lead to bladder outlet obstruction and lower urinary tract symptoms (LUTS), including poor urinary stream, increased frequency of urination, dysuria and difficulty in voiding.

Benign Prostatic Hyperplasia (BPH): Symptoms & Treatment

Image Source: clevelandclinic; Benign Prostatic Hyperplasia

This case report describes a 59-yrear-old male patient diagnosed with BPH and Type 2 diabetes mellitus who prevented with lower urinary tract symptoms. Following clinical evaluation and investigations, the patient underwent Rezum prostate ablation.

Introduction

Benign Prostatic Hyperplasia (BPH) is a common, progressive, non-malignant enlargement of the prostate gland that predominantly affects ageing men. It occurs due to the proliferation of both glandular epithelial and stromal components of the prostate, leading to an increase in prostate may compress the prostatic urethra, resulting in bladder outlet obstruction and various Lower Urinary Tract Symptoms (LUTS). BPH is an important urological health problem that can significantly affect urinary function, sleep quality, daily activities and overall quality of life. The prostate gland is a walnut – sized organ located below the urinary bladder and surrounding the proximal portion of the urethra. It plays an important role in male reproductive function by producing prostatic fluid, which forms a component of semen. With increasing age, hormonal changes, particularly the influence of dihydrotestosterone (DHT), contribute to the development and progression of prostatic enlargement. Although BPH is a benign condition, untreated or progressive enlargement may result in significant urinary complications.

Clinical manifestations

Patients with BPH commonly present with lower urinary tract symptoms, which are broadly classified into two categories:

Voiding (Obstructive) Symptoms:

  • Hesitancy during urination.
  • Weak or Poor urinary stream.
  • Intermittent urinary flow.
  • Straining during micturition.
  • Incomplete bladder emptying.
  • Terminal dribbling.

Storage (Irritative) Symptoms:

  • Increased frequency of urination.
  • Nocturia.
  • Urgency.
  • Urge urinary incontinence.

Some patients may also experience dysuria, recurrent urinary tract infections, acute urinary retention and Hematuria.

Pathophysiology of Benign Prostatic Hyperplasia (BPH)

Ageing (Increasing Age)

▼

Hormonal changes

Increased influence of dihydrotestosterone (DHT)

▼

Conversion of testosterone into DHT

By the enzyme 5 – Alpha reductase

▼

Increased prostatic cell proliferation

Decreased cellular apoptosis

▼

Hyperplasia of glandular and stromal tissues.

▼

Enlargement of the prostate gland

▼

Compression of prostate urethra

Narrowing of the urethral passage

▼

Increased resistance to urinary flow

Bladder Outlet Obstruction

▼

Increased workload on urinary bladder

Detrusor muscle over activity and hypertrophy

▼

Bladder wall thickening and trabeculation

▼

Incomplete emptying of urinary bladder

Increased post – void residual urine.

Patient details

  • Name: xx, Age: 59 years old male
  • Final diagnosis: Benign prostatic hyperplasia (BPH)
  • Type 2 diabetes mellitus

Chief complaints

The patient presented the following complaints:

  • Pain during micturition
  • Poor urinary flow
  • Lower abdomen pain
  • Weak urinary stream
  • Increased frequency of urination
  • Dysuria

The patient was electively admitted for the admission for the planned procedure

Past medical and surgical history: Known case of Type II diabetes mellitus on medication History of renal calculi approximately 25 years back

Clinical examination

General examination

  • Temperature: Afebrile
  • Pulse rate: 72 , Blood pressure: 120/80 mmHg
  • SpO2 -98 % in RA

Systemic examination

  • CVS: S1 and S2 normal
  • Respiratory system -Breth sounds vesicular
  • P/A -Soft, Nontender
  • CNS: No focal neurological deficit

Diagnostic evaluation: The patient was evaluated relevant investigations before the planned surgical procedure

Procedure

Rezum prostate ablation done under general anesthesia on 13/10/2026. The patient underwent rezum prostate ablation under general anesthesia after obtaining informed written consent and completing preoperative fitness evaluation

A successful benign prostatic hyperplasia managed by rezum prostate ablation - figure 2

Image Source: Bostonscientific, Rezūm™ Water Vapor Therapy

A successful benign prostatic hyperplasia managed by rezum prostate ablation - figure 3

Image Source: Bostonscientific Rezūm™ Water Vapor Therapy

Intra operative findings

Cystoscopy examination revealed:

  • Meatus – Normal
  • Urethra -Normal
  • Verumontanum -Normal
  • Prostate – Grade II lateral occlusive lobes
  • Median lobe -Grade I
  • Bladder Neck -High
  • Urinary bladder -Trabeculation present
  • Bilateral ureteric orifices – Normal
  • These findings were consistent with benign prostatic enlargement causing bladder outlet obstruction

Rezūm™ Water Vapor Therapy for BPH - Gulfstream Urology Associates, P.A. - Dr. Adam Ball

Image Source: Gulfstreamurology, Rezūm™ Water Vapor Therapy for BPH

Course in the hospital and discussion

The 59 years old male patient was admitted to the urology department with the complaints of dysuria, poor urinary flow, weak stream, increased frequency of urination and lower abdomen pain. He was evaluated clinically and relevant investigations were carried out. He was diagnosed with benign prostate hyperplasia with underlying type II DM. After obtaining informed written consent and performing preoperative fitness the patient underwent Rezum prostate ablation under general anesthesia on 13/10/2026. The procedure was completed successfully. Following the procedure patient was shifted to the post-operative recovery area for observation. The vital signs, hemodynamic status and urine output and colour were monitored. The urinary catheter was kept in situ to ensure adequate urinary drainage and to prevent postoperative urinary retention due to temporary prostate edema and inflammation The patient remained stable and discharged with a urinary catheter in situ. overall, the patient had an uneventful hospital course following the rezum prostate ablation.

Post operative management

Post-operative care included,

  • Monitoring of vital signs
  • Monitoring of urine output and its appearance
  • Maintaining adequate hydration
  • Catheter care
  • Monitoring for Hematuria & clots retention
  • Monitoring for postoperative urinary retention
  • Administration of prescribed medication Regularly
  • Monitoring of blood glucose levels due to underlying type II DM

Medication at discharge

Discharge medication:

  • Tab. Cefixime 200mg 1-0-1 x 7 days
  • Tab. Alfuzosin 10mg 0-0-1 x 2 months
  • Tab. Pan D 40 mg 1-0-0 (B/F) x 3 days
  • Tab. Dolo 650mg 1-0-0 x 2 days
  • Tab. Zerodol P /SOS
  • Syp. Lactulose 15ml -HS
  • Tab. Carbophage 500mg 0-2-1 x to continue

Diet and physical activity

  • Soft diet advised
  • Maintain adequate fluid intake
  • Consume approximately 3 liters of fluids per day
  • Avoid excessive salt intake
  • Follow postoperative instruction as advised
  • Avoid strenuous activities until reviewed by urologist

Discharge advice and follow-up

  • Patient discharged in stable condition with urinary catheter in situ
  • Maintain proper catheter hygiene
  • Monitor urine output and colour
  • Review after 10 days / for catheter removal and uroflowmetry /PVR assessment
  • To see immediate medical attention in case of fever/ severe pain / hematuria /catheter blockage & reduced urinary output.

Discussion

  • Benign prostatic hyperplasia is a common cause of bladder outlet obstruction in elderly males. Persistent obstruction may result in changes in bladder function, including bladder wall thickening and trabeculation
  • Rezum water vapour therapy is a minimally invasive treatment modality that uses thermal energy delivered through water vapour to cause targeted destruction of excess prostatic tissue. Over time, the treated tissue is absorbed, resulting in a reduction in prostate volume and improvement in urinary flow
  • In this patient, cystoscopy demonstrated Grade I median lobe, a high bladder neck and trabeculation. Rezum prostate ablation was performed under general anaesthesia. Patient had an uneventful post-operative recovery and discharged with urinary catheter. Follow up was planned for catheter removal and assessment of urinary flow and post – void residual volume.

Advantages of Rezum therapy

  • The important advantages of rezum water vapour therapy include:
  • Minimally invasive treatment approach
  • No major surgical incision

Conclusion

This case highlights the management of symptomatic Benign prostatic hyperplasia in a 59-year-old male patient with Type II DM using Rezum prostate ablation. The procedure was completed and the patient had an uneventful postoperative recovery. He was discharged in stable condition with a urinary catheter in situ and advised regular follow up for catheter removal and assessment of urinary function. This case highlights the role of Rezum water vapour therapy as a minimally invasive treatment option appropriately selected patient with BPH. Proper postoperative care, glycemic control, medication compliance and regular follow up are important for achieving favourable long -term outcomes and improving the patient’s quality of life.

Kauvery Hospital